-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Arcturus Therapeutics Holdings Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2023.
- Arcturus Therapeutics Holdings Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$6.9M, a 57.4% increase year-over-year.
- Arcturus Therapeutics Holdings Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$62.6M, a 163% decline year-over-year.
- Arcturus Therapeutics Holdings Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$29.7M, a 418% decline from 2022.
- Arcturus Therapeutics Holdings Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $9.35M.
- Arcturus Therapeutics Holdings Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$204M, a 182% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)